Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Infections × anifrolumab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 1 drotrecogin alfa activated 1 anifrolumab 1 Vancomycin 1 Teicoplanin 1 Rituximab 1 Mannose-Binding Lectin 1 Lenalidomide 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07000110 2026-02-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡